The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $4.63, representing a -3.14% change from its previous ...
Recursion Pharmaceuticals Inc. stocks have been trading down by -4.08 percent after cautious reaction to its latest AI ...
Recursion’s August business update highlighted that Genentech opted its first neuroscience target into an early discovery ...
Across the ARK Genomic Revolution ETF and the ARK Innovation ETF, Wood bought $6.1 million in Recursion Pharmaceuticals, $1.2 million in Intellia Therapeutics, and $5.3 million in Veracyte.
Cathie Wood's ARK Invest executed a $22 million healthcare portfolio rotation on Monday, selling approximately $18 million of ...
Recursion Pharmaceuticals Inc. stocks have been trading up by 15.41 percent amid heightened optimism over its AI-driven drug ...
Recursion Pharmaceuticals Inc. surged as breakthrough AI-driven drug discovery progress fueled bullish sentiment, and stocks ...
ARK Invest sold Twist Bioscience shares and bought Recursion Pharmaceuticals, Intellia Therapeutics, and Veracyte stock on ...
Investor's Business Daily on MSN
Stock market today: Dow, S&P 500 rally; Cathie Wood buys this stock amid 56% dive
The Dow Jones index rises on the stock market today but Seagate falls on a report. AMD pops. Zebra and an AI stock test ...
Tempus AI Inc. stocks have been trading up by 6.55 percent after bullish coverage on its AI-driven healthcare data platform.
ARK Invest sold $17.1M in Twist Bioscience shares and purchased Recursion Pharmaceuticals, Intellia Therapeutics, and ...
Pune, India, October 6th, 2026, FinanceWireThis is a paid advertisement.Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results